Old Web
English
Sign In
Acemap
>
Paper
>
187P Nivolumab-related immune-related adverse events in advanced NSCLC predict therapeutic objective response
187P Nivolumab-related immune-related adverse events in advanced NSCLC predict therapeutic objective response
2018
J. Rogado
V. Pacheco Barcia
B Vera
P. Toquero
R. Mondejar
A.I. Ballesteros García
O. Donnay
N. Romero Laorden
R. Colomer Bosch
J.M. Sánchez Torres
Keywords:
Nivolumab
Pathology
Immune system
Adverse effect
Cancer research
Medicine
Oncology
objective response
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]